SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Vicenza Hospital, Ospedale Civile San Bortolo in Italy has become the first European hospital to purchase a second CyberKnife(R) Robotic Radiosurgery System.
"As the clinical benefits of CyberKnife radiosurgery have evolved beyond brain and spine tumors into extracranial applications, such as lung and prostate, we have seen the number of radiosurgery cases increase significantly over the past few years. With the purchase of a second CyberKnife System, we will be able to meet this high demand for precise, accurate radiosurgical treatment throughout the body while still maintaining short waiting times for our patients with intracranial and spine tumors, and AVMs," said Professor Federico Colombo, Director of the Neurosurgical Department at Vicenza Hospital. "The CyberKnife's ability to deliver accurate radiosurgical treatments quickly and easily anywhere in the body was a decisive factor in choosing our second system."
In 2003, Vicenza Hospital was the first facility in Europe to install a CyberKnife System, which has been used primarily to treat arteriovenous malformations (AVM) and benign tumors in the brain such as neuromas and meningiomas. To date, the hospital, which is located in the Venetian region of Italy, has treated almost 1,800 patients with the CyberKnife System.
"As CyberKnife radiosurgery has evolved to address tumors anywhere in the
body, demand for the treatment often becomes more than a single CyberKnife
System can accommodate," said Euan S. Thomson, Ph.D., president and CEO of
Accuray. "Vicenza Hospital's expansion echoes a trend we have been witnessing
in the United States, in which facilities require multiple CyberKnife Systems
|SOURCE Accuray Incorporated|
Copyright©2008 PR Newswire.
All rights reserved